FindMyKOL
Clinical trialNCT05317819RecruitingPhase 3Interventional

Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma

SponsorPolaris GroupEnrollment300Advanced Hepatocellular CarcinomaHepatocellular Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Evaluate efficacy and safety of ADI-PEG 20 in patients with high-argininephenotypic and HCC

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Taiwan
  • Changhua Christian Hospital (cch)

    Changhua, Taiwan

    Recruiting
  • Chang Gung Medical Foundation-Chia-Yi (cgmf-Cy)

    Chiayi City, Taiwan

    Recruiting
  • Ditmanson Medical Foundation Chiayi Christian Hospital (cych)

    Chiayi City, Taiwan

    Recruiting
  • Chang Gung Medical Foundation-Kaohsiung(cgmf-Ks)

    Kaohsiung City, Taiwan

    Recruiting
  • Kaohsiung Medical University Chung-Ho Memorial Hospital (kmuh)

    Kaohsiung City, Taiwan

    Recruiting
  • Chi Mei Hospital, Liouying (cmmc-Ly)

    Tainan, Taiwan

    Recruiting
  • Chi Mei Medical Center (cmmc-Yk)

    Tainan, Taiwan

    Recruiting
  • Chang Gung Medical Foundation-Linkou (cgmf-Lk)

    Taoyuan, Taiwan

    Recruiting
Vietnam
  • Bach Mai Hospital

    Hanoi, Vietnam

    Not, yet, recruiting
  • Hue Central Hospital

    Huế, Vietnam

    Not, yet, recruiting
  • K Hospital

    Hà Nội, Vietnam

    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Pegargiminase
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Mar 2022
Primary completion
30 Sept 2028
Completion
31 Dec 2028
Last update posted
18 Dec 2025
Registered enrollment
300
Registry id
NCT05317819

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.